Brief: Nurix Therapeutics Announces Pricing Of Upsized $175 Mln Public Offering
12/04/2024 04:39
April 11 (Reuters) - Nurix Therapeutics Inc NRIX.O :
* NURIX THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $175.0
MILLION
PUBLIC OFFERING
* NURIX THERAPEUTICS INC - PRICING OF ITS UPSIZED
UNDERWRITTEN
PUBLIC OFFERING OF 10.2 MILLION SHARES OF ITS COMMON STOCK AT
$15.00 PER SHARE
Source text for Eikon: ID:nGNXb7wr6R
Further company coverage: NRIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nurix Therapeutics
See all newsNurix Therapeutics Q3 swings to profit on Roche collaboration
Brief: Nurix Extends Gilead Collaboration For Oncology Program
Commercialize Potential Best-In-Class Btk Degrader Bexobrutideg Across Malignant Hematology, Immunology And Neurology
Nurix Therapeutics Q2 revenue falls sharply, net loss widens; strikes up to $2.3 bln collab with Roche
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis